Ethical, legal, organizational and social issues related to the use of scalp cooling for the prevention of chemotherapy‐induced alopecia: A systematic review
Metadatos
Mostrar el registro completo del ítemAutor
Delgado Rodríguez, Janet; Ramos García, Vanesa; Infante Ventura, Diego; Suarez Herrera, José Carlos; Rueda Domínguez, Antonio; Serrano Aguilar, Pedro; Trujillo Martín, María del MarEditorial
Wiley
Materia
chemotherapy‐induced alopecia ethical, healthcare professional perspective legal, organizational and social issues
Fecha
2022-12-30Referencia bibliográfica
Delgado Rodríguez J, Ramos‐García V, Infante‐Ventura D, et al. Ethical, legal, organizational and social issues related to the use of scalp cooling for the prevention of chemotherapy‐induced alopecia: a systematic review. Health Expect. 2023;26:567‐578. doi:10.1111/hex.13679
Patrocinador
Ministre of Health (Spain)Resumen
Introduction: Scalp cooling (SC) aims to prevent chemotherapy‐induced alopecia.
The goal of this systematic review is to tackle ethical, legal, organizational and social
issues related to SC.
Methods: A critical appraisal of the literature was carried out using a systematic
review design. MEDLINE, Embase and Web of Science databases were searched up
until 2 June 2021. Studies addressing these aspects in English or Spanish were
considered. Representatives of both patient associations and professional scientific
societies related to the topic participated in the design of the protocol and the
review of the findings.
Results: A total of 17 studies were included. Articles were critically appraised using
the MMAT and SANRA. Findings were organized into four categories: (1) ethical
aspects focused on equal access, gender equity and doctor–patient communication
supported by Patient Decision Aids (PtDAs); (2) patient perspective and acceptability;
(3) professional perspective and acceptability; (4) organizational aspects focused on
accessibility and feasibility.
Conclusion: Cancer patients' expectations when using SC need to be adjusted to
reduce the potential distress associated with hair loss. PtDAs could help patients
clarify their values and preferences regarding SC. Equal access to technology should
be guaranteed.
Patient or Public Contribution: In this systematic review, the representatives of the
patient associations (Ms. María Luz Amador Muñoz of the Spanish Association Against Cancer [AECC] and Ms. Catiana Martinez Cánovas of the Spanish Breast
Cancer Federation [FECMA]) participated in the review of the study protocol, as well
as in the results, discussion and conclusions, making their contributions. In the type
of design of these studies (systematic reviews), it is not usual to have the direct
participation of patients, but in this one, we have done so, as it is a systematic review
that is part of a report of the Spanish Network of Health Technology Assessment
Agencies (ETS).